Karen joined Isomerase in April 2018. Karen brings 20 years of financial experience, across various industries, including the biotech, property and media industries. Prior to joining Isomerase Therapeutics Limited, Karen worked as Financial Controller at Mission Therapeutics Limited, a VC-backed biotech company. During her time at Mission she assisted in implementing numerous improved financial processes and controls as well as implementing a new finance system. Prior to this, Karen was Financial Controller at The Whitfield Group, a privately-owned property owning & letting business where she was responsible for all aspect of finance and also sat on the operational and management leadership team assisting to make strategic decisions. Prior to this, Karen spent 6 years at BSkyB Plc, where she held a number of Finance roles including 3 years within Group Finance, liaising closely with auditors as well as in-house tax, treasury and legal teams.
Karen trained and qualified as an ACA with KPMG and has a BA (Hons) Business degree.